26th -
27th
March 2025
March 2025 | 
Hilton Taipei Sinban, Taiwan

11 Years of Innovation: Taiwan’s ONLY Biologics, Vaccines & Stem Cells Summit

26th -
27th
March 2025 | 
Hilton Taipei Sinban, Taiwan
📆 Add to Google Calendar
Attendees
0 +
Companies
0 +
Speakers
0 +
In-Person Networking Hours
0 +
Case Studies
0 +

Since its inception in 2012, Biologics World Taiwan has experienced remarkable success by gathering over 300 pioneers in the biologics industry from Taiwan and around the world. Dedicated to fostering the development and manufacturing of high-quality biologic drugs, vaccines, stem cells, and regenerative medicines in Taiwan for the global market, Biologics World Taiwan 2025 is poised to continue its impactful legacy.

This year's conference will delve into a spectrum of pivotal topics, including must-see innovations originating from Taiwan, best practices in clinical research and trials, optimization of upstream processing, cost reduction in downstream processes, advancements in CAR-T and stem cell therapy, compelling case studies in regenerative medicines, and more. The agenda promises the most comprehensive coverage of Taiwan's biologics development and manufacturing landscape.

By participating in the conference, attendees will have the opportunity to engage with key and emerging entities within Taiwan's Biologics and Vaccine space, including distinguished organizations such as PharmaEssentia, Eirgenix, Mycenax, Medigen Biotechnology Corp, Lumosa Therapeutics, and others. If Taiwan stands out as a region rich in opportunities within the bio-manufacturing, vaccine, and cell therapy sectors, then Biologics World Taiwan 2025 is the definitive event to attend.

Discover the latest developments in Taiwan's biologics manufacturing sector, spanning from current best R&D practices to the trajectory towards advanced manufacturing. Immerse yourself in recent, exclusive case studies and gain insights into the industry's key needs—all under one roof! Don't miss this opportunity to stay at the forefront of Taiwan's dynamic biologics landscape.

FEATURED CONTENT

eBook Thumbnail
Taiwan's Top 123 Biopharma Innovators for 2025: A Biopharma & CDMO Directory
booming-banner
Taiwan's Booming Biopharma: Biologics and Regenerative Medicines Pipeline
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Untitled-design-19-1024x1024
Biologics World Taiwan Attendee List 2023
Untitled-design-10-1024x1024
Why Global Giants Are Betting Big on Taiwan
new-ebook-cover-1024x1024
Empowering Biologics Innovation, The Future Begins Here
MicrosoftTeams-image-2022-09-22T125547.419
Taiwan's Cell & Gene Therapy Landscape
ebook-cover-page-1024x1024
Emerging Taiwan Biologics Industry Now and Future 2022
cover photo
Biologics World Taiwan 2023 Post Event Report
Untitled design (5)
Exploring Taiwan's Biotechnology Hubs
Taiwan’s Leading Biopharma
Taiwan’s Leading Biopharma in Phase 3 Clinical Pipelines
12th Biologics World Taiwan 2025

Explore the best practices of clinical development & trials with the ultimate goal of bringing new biologics products with proven therapeutic effect to the market. Learn how important the transition of preclinical research to clinical stages can mark a critical turning point of new biologics development.

Process optimization is the key success factor to develop biomanufacturing practices with high productivity and reduced cost. Immerse in the latest technology from Taiwan about the key practices to enhance productivity and speed in producing biologics.

The emerging CMO leaders from Taiwan are about to share their success stories with valuable insights and case studies to deliver the next generation manufacturing capabilities that Taiwan is providing to the world in making first class biologics products that can save millions of lives.

Antibody and Protein therapeutics are emerging as the most promising class of diagnostics to treat diseases in humans. Innovative sharing and case studies of effective antibody and protein treatments will be shared by the experts.

Innovative strategy of assay optimization, real time monitoring system with highest compromisation to quality control of biologics products to a direction of improving efficiency while advocating process automation are the keys to quicker market commercialization and regulatory compliance. Topics built around cost and process optimization with latest developments in analytics and quality to foster biologics enhancement.

Gain insights on the latest case studies of stem cell and regenerative medicine and recognize the potential of the cell and gene therapies.

Explore the latest CAR-T cell therapy advancements with impressive and effective solutions for antitumor treatments, especially against hematological malignancies from Taiwan’s key leaders in the CAR-T cell therapy industry.

Immerse in the best practices of cell & gene therapy products from the innovative showcase of the Taiwan market while considering the key factors and strategy that can lead to successful scale up and manufacturing of the products.

Listen to the key industry leaders of cell & gene therapy about their success stories of making the commercialization of the products a successful ones while replicating the strategies of effective manufacturing and commercialization in the market.

THANK YOU TO OUR SUPPORTING PARTNERS









12th Biologics World Taiwan 2025

Past Speakers

Abigail-Pittman

Abigail Pittman

Special Assistant to the CEO

PELL BIO-MED TECHNOLOGY
Taiwan
Albert-Yueh-Peng-Hung_photo_profile-2

Albert Yueh-Peng Hung,

Deputy Chief Operating Officer, Adimmune Corp, Taiwan

Alex-Blyth_photo_profile-2

Alex Blyth

CEO, LIft Biosciences, UK

UK
no-picture

Austin Tsai

Assistant Vice President,

Maria Von
Taiwan
Cheng-Han-Tsai_photo_profile-3

Cheng-Han Tsai

CEO, Cytena, Taiwan

Cheng-Yi Jerry Kuo photo

Cheng-Yi Jerry Kuo

Vice General Manager,

UWELL BioPharma
Taiwan
ChiaChu-Tsai_photo_profile-2

ChiaChu Tsai

Co-Founding Partner, COO, CellTech Innovation Studio Co., Taiwan

Dar-Jen-Hsieh_photo_profile

Dar-Jen Hsieh

CEO, ACRO Biomedical Co., Ltd.

Taiwan
Donggeon-Kim_photo_profile-2

Donggeon Kim

DVM, Ph.D. Principal Scientist Kanaph therapeutics, S Korea

Hem-Reddy_photo_profile-3

Hem Reddy

Director of APAC Business Development,

Pfanstiehl Inc.
USA
Jan-Mou-Lee_photo_profile

Jan Mou Lee

Founder & Scientific Advisor, Fullhope Biomedical Co., Ltd

Taiwan
Jason-Huang-M.D-J.D._photo_profile

Jason Huang M.D ; J.D.

CEO/CMO of ASCENDO Biotech

Taiwan
Julio-Lin_photo_profile

Julio Lin

Vice President

Blue Blood Biotech
Taiwan
Karen-Wen-Ph.D._photo_profile

Karen Wen, Ph.D.

COO and Chief Strategy Officer, GenomeFrontier Therapeutics, Inc

Taiwan
Kevin-Chih-Yuan-Ho_photo_profile

Kevin Chih-Yuan Ho

Director of Clinical Department, Steminent Biotherapeutics Inc.

Taiwan
Li-Ming-Lu_photo_profile-3

Li-Ming Lu

Senior Clinical Project Manager, ARCE Therapeutics, Taiwan

Pearl-Fong_photo_profile-3

Pearl Fong

Development Manager, Eirgenix, Taiwan

Shugene-Lynn_photo_profile

Shugene Lynn

CEO and President, United BioPharma

Vatsala-Sadasivan_photo_profile

Vatsala Sadasivan

Global Operational Excellence Lead- R&D, Sanofi

no-picture

Verena Tan Wan Ying

Product Specialist, Chromatography

APAC Sartorius
Taiwan
Yan-Jye-Shyong_photo_profile

Yan-Jye Shyong

Assistant Professor, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University

Taiwan
Yen Choo

Yen Choo

Founder & Chairman, Assoc. Professor of Stem Cell Science and Regenerative Medicine

Plasticell Ltd, Lee Kong Chian School of Medicine
Singapore
Yun-Chi-Lu_photo_profile

Yun-Chi Lu

PhD., Chief Executive Officer, PrecisemAb Biotech, Taiwan

2025

SPEAKERS

Featuring esteemed voices from the biopharmaceutical sector. Our selected experts will share insights on the latest trends, challenges, and developments in this dynamic field. Engage in unique discussions, learn about cutting-edge scientific discoveries, and explore the future of biopharmaceuticals with these influential thought leaders. Don't miss this chance to broaden your understanding of this ever-evolving industry.

Aprilia-Paramitasari_photo_profile

Aprilia Paramitasari

Medical Doctor

Taipei Medical University
Taiwan
no-picture

Charles Hou

Director of Biologics Research & Development

Holy Stone Healthcare
Taiwan
Cheng-Yi Jerry Kuo photo

Cheng-Yi Jerry Kuo

Vice General Manager,

UWELL BioPharma
Taiwan
Chi-Jung Liang

Chi-Jung Liang

Manager, R&D Department

UnicoCell Biomed Co., Ltd.
Taiwan
Chiao-Wen Chen _ DCB

Chiao-Wen Chen

Executive Director, Institute of Drug Evaluation Platform

Development Center for Biotechnology
Taiwan
Chih-Kai Hsu

Chih-Kai Hsu

Director of Mitochondria Process Development

Taiwan Mitochondrion Application Technology Co., Ltd,
Taiwan
AVATAR IMAGE

Chuang Simon Shih-Hsien

Chief Executive Officer

HoneyBear Biosciences
Taiwan
Ping-Yang, Yeh, Ph.D.

Dr. Ping-Yang Yeh

President

Altrubio Taiwan
Taiwan
WFLi

Dr. Wan-Fen Li

Development Champion, Development Team

OBI Pharma
Taiwan
AVATAR IMAGE

Dr. Wen Chyi Shyu

Chief Executive Officer

BRIM Biotechnology
Taiwan
AVATAR IMAGE

Dr. Yu-Hsiang Chang

Chief Executive Officer & Chief Medical Officer

Locus Cell
Taiwan
路迦生醫 唐稚超 董事長

Eric Tang

Chairman & General Manager

Lukas Biomedical
Taiwan
Jen-Chih Chi_BeiGene

Jen-Chih Chi

Director of Cell Therapy CMC

BeiGene
Taiwan
Evoto

Jih-Hung Guo

Manager of Cell Line Process Development

Mycenax
Taiwan
Juine-Ruey-Chen _ RuenHuei Biopharma

Juine-Ruey Chen

Chief Operating Officer

RuenHuei Biopharma
Taiwan
Julio-Lin_photo_profile

Julio Lin

Vice President

Blue Blood Biotech
Taiwan
AVATAR IMAGE

Kuo-Hsiang Chuang

Chief Executive Officer

CytoArm
Taiwan
Kwang Joon Yoon

Kwang Joon Yoon

Managing Director and Head of Business Planning Department Cell and Gene Therapy CDMO

Matica BIOLABS
South Korea
Min-Shi Lee _ Taiwan Universe Biomedicine

Min-Shi Lee

Investigator, National Institute of Infectious Diseases and Vaccinology, National Health Research Institute, Co-Founder

Taiwan Universe Biomedicine (Tai-U)
Taiwan
Vivian Kuo

Vivian Kuo

Senior Director CMC,

HanchorBio,
Taiwan
William-Hung-Ph.D._photo_profile

William Hung, Ph.D.

Assistant General Manager, Maria Von

Taiwan
Xiaotong Song

Xiaotong Song

PhD, Associate Professor, Translational Medical Science Department, School of Medicines Texas A&M University

Founding CEO of Cellula Biopharma
USA

DELEGATE REGISTRATION

APAC Biopharma / Academic
SGD 1,895

EARLY (until 24th January 2025)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes in Taiwan and APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

NON-APAC Biopharma / Academic
SGD 2,395

EARLY (until 24th January 2025)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: International Biopharma, BIG Pharmas, Academic & Research Institutes outside APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

Service or Solution Provider
SGD 3,595

EARLY (until 24th January 2025)

*SOLUTION PROVIDER PRICING IS APPLICABLE TO:

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

DELEGATE REGISTRATION

Catch the limited super access in time to save BIG!

APAC Biopharma / Academic
SGD 1,895

EARLY (until 24th January 2025)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: Biopharma, BIG Pharmas, Academic & Research Institutes in Taiwan and APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

NON-APAC Biopharma / Academic
SGD 2,395

EARLY (until 24th January 2025)

*THIS PRICING IS APPLICABLE TO:

Company Profiles: International Biopharma, BIG Pharmas, Academic & Research Institutes outside APAC

Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.

Service or Solution Provider
SGD 3,595

EARLY (until 24th January 2025)

*SOLUTION PROVIDER PRICING IS APPLICABLE TO:

Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, CRO's, Asian Academic/Research Institutes.

Job Profiles: Business Development, Marketing & Sales

Taiwan Biopharma Excellence Awards 2025

 6:00 PM – 7:30 PM

26th March 2025

FEATURED CONTENT

eBook Thumbnail
Taiwan's Top 123 Biopharma Innovators for 2025: A Biopharma & CDMO Directory
booming-banner
Taiwan's Booming Biopharma: Biologics and Regenerative Medicines Pipeline
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Survey Infographic - Taiwan's Challenges and Opportunities in Biologics Development
Untitled-design-19-1024x1024
Biologics World Taiwan Attendee List 2023
Untitled-design-10-1024x1024
Why Global Giants Are Betting Big on Taiwan
new-ebook-cover-1024x1024
Empowering Biologics Innovation, The Future Begins Here
MicrosoftTeams-image-2022-09-22T125547.419
Taiwan's Cell & Gene Therapy Landscape
ebook-cover-page-1024x1024
Emerging Taiwan Biologics Industry Now and Future 2022
cover photo
Biologics World Taiwan 2023 Post Event Report
Untitled design (5)
Exploring Taiwan's Biotechnology Hubs
Taiwan’s Leading Biopharma
Taiwan’s Leading Biopharma in Phase 3 Clinical Pipelines

#BUZZ ABOUT THE EVENT

SIMILAR EVENTS

Register Now. SAVE BIG!

Download Post Event Report Form

Download Participating Companies

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Attendee List

Download Prospectus Document Form

Brochure Form

Sponsorship Form

IMAPAC requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and to learn more about our privacy practices and our commitment to protecting your privacy, please review our Privacy Policy.

Download Agenda Form